← back to search

Bénédicte Delcoigne

Karolinska Institutet · SE
Area of research
Rheumatology · Immunology
Research interest
Research interests include Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments, Systemic Lupus Erythematosus Research, and Psoriasis: Treatment and Pathogenesis.
h-index
16
citations
980
works
75
NIH funding
primary concept
email

Recent publications

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme
Annals of the Rheumatic Diseases 2023cited by 87position: middledoi
Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis
RMD Open 2023cited by 19position: middledoi
Glucocorticoid exposure and the risk of serious infections in rheumatoid arthritis: a marginal structural model application
Lara D. Veeken 2023cited by 17position: middledoi
Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis
Annals of the Rheumatic Diseases 2022cited by 88position: middledoi
A Healthy Lifestyle in Men at Increased Genetic Risk for Prostate Cancer
European Urology 2022cited by 65position: middledoi
Comorbidities and treatment patterns in early rheumatoid arthritis: a nationwide Swedish study
RMD Open 2022cited by 22position: middledoi
Impact of the COVID-19 pandemic on morbidity and mortality in patients with inflammatory joint diseases and in the general population: a nationwide Swedish cohort study
Annals of the Rheumatic Diseases 2021cited by 101position: middledoi
Effectiveness and treatment retention of TNF inhibitors when used as monotherapy versus comedication with csDMARDs in 15 332 patients with psoriatic arthritis. Data from the EuroSpA collaboration
Annals of the Rheumatic Diseases 2021cited by 54position: middledoi
Blood neurofilament light levels segregate treatment effects in multiple sclerosis
Neurology 2020cited by 139position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Johan Askling · Karolinska University Hospital6 papers (2021–2023)Thomas Frisell · Karolinska Institutet5 papers (2021–2023)Daniela Di Giuseppe · Karolinska Institutet4 papers (2021–2023)Hannah Bower · Karolinska Institutet4 papers (2021–2023)Nils Feltelius · Uppsala University2 papers (2021–2023)Eva Baecklund · Science for Life Laboratory2 papers (2021–2023)Elisabet Lindqvist · Lund University2 papers (2021–2023) · 2 papers (2021–2023)Helena Forsblad‐d’Elia · Lund University2 papers (2021–2023)Helga Westerlind · Karolinska Institutet1 papers (2022–2022)Ali Manouchehrinia · Alberta Health Services1 papers (2020–2020)Viktor Molander · Karolinska Institutet1 papers (2022–2022)Yiwen Zhang · Shenyang Pharmaceutical University1 papers (2022–2022)Bernd C. Kieseier · Novartis (Switzerland)1 papers (2020–2020)Jon A. Tsai · Dana-Farber Cancer Institute1 papers (2020–2020)Jan Lycke · Sahlgrenska University Hospital1 papers (2020–2020)Katerina Chatzidionysiou · Karolinska University Hospital1 papers (2021–2021)Arvid Sjölander · Karolinska Institutet1 papers (2023–2023)Tatiana Plavina · Takeda (United States)1 papers (2020–2020)Zuzanna Michalak · University College London1 papers (2020–2020)